<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00642330</url>
  </required_header>
  <id_info>
    <org_study_id>IBU-001</org_study_id>
    <secondary_id>TIS-1447</secondary_id>
    <secondary_id>FMND-4585</secondary_id>
    <nct_id>NCT00642330</nct_id>
  </id_info>
  <brief_title>Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants</brief_title>
  <official_title>Randomized Pilot Study Comparing Oral Ibuprofen With Intravenous Ibuprofen in Very Low Birth Weight Infants With Patent Ductus Arteriosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital La Rabta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>maternity and neonatal center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hopital La Rabta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      it is a prospective randomized simple-blinded pilot trial with the principal aim to compare
      efficacy and tolerance between oral ibuprofen and intravenous ibuprofen in early curative
      closure of PDA in very low birth weight infants. The likelihood of ductal closure with only
      one or two doses of treatment is a secondary objective.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We calculated that a study group of 62 patients would be necessary for the study to be able
      to detect a difference of at least 25 percentage points in the closure rate between the oral
      ibuprofen and intravenous ibuprofen groups, assuming a closure rate of 65 percent with
      intravenous ibuprofen, with a p value of 0, 05 and a power of 80 percent.Patients
      (gestational age, 25 to 32 weeks) with echocardiographically confirmed patent ductus
      arteriosus and respiratory distress will randomly be assigned to receive one (10 mg / kg),
      two (10 mg / kg followed 24 hours after by 5 mg /kg) or three (10 mg / kg followed at 24-hour
      intervals by two doses of 5 mg /kg each) doses of either intravenous ibuprofen (group I, n =
      32) or oral ibuprofen (group O, n = 32), starting on the third day of life. The rate of
      ductal closure, side effects, complications, and the patients' clinical course will be
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rate of ductal closure</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of side effects</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Patent Ductus Arteriosus</condition>
  <arm_group>
    <arm_group_label>I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>O</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oral ibuprofen</intervention_name>
    <description>one (10 mg / kg), two (10 mg / kg followed 24 hours after by 5 mg /kg) or three (10 mg / kg followed at 24-hour intervals by two doses of 5 mg /kg each) doses of oral ibuprofen starting on the third day of life.the number of doses is depending on echocardiographic findings concerning ductal closure.</description>
    <arm_group_label>O</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous ibuprofen</intervention_name>
    <description>one (10 mg / kg), two (10 mg / kg followed 24 hours after by 5 mg /kg) or three (10 mg / kg followed at 24-hour intervals by two doses of 5 mg /kg each) doses of oral ibuprofen starting on the third day of life.the number of doses is depending on echocardiographic findings concerning ductal closure.</description>
    <arm_group_label>I</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a gestational age &lt; 32 weeks

          -  a birth weight &lt; 1500g

          -  a postnatal age between 48 and 96 hours, a respiratory distress requiring more than 25
             % of oxygen supplementation

          -  an echocardiographic evidence of left to right significant shunting PDA

        Exclusion Criteria:

          -  a right-to-left shunting

          -  major congenital anomalies

          -  IVH grade 3-4

          -  a tendency to bleed (defined by the presence of blood in the endotracheal aspirate,
             gastric aspirate, stools or urines and / or oozing from puncture sites)

          -  a serum creatinine level &gt;140µmol/l, a serum urea nitrogen &gt; 14 µmol/l and a platelet
             count &lt; 60000/mm3.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>96 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maternity and Neonatal Center</name>
      <address>
        <city>Tunis</city>
        <zip>1007</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <results_reference>
    <citation>Cherif A, Jabnoun S, Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol. 2007 Jun;24(6):339-45. Epub 2007 Jun 12.</citation>
    <PMID>17564958</PMID>
  </results_reference>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2008</study_first_submitted>
  <study_first_submitted_qc>March 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2008</study_first_posted>
  <last_update_submitted>March 24, 2008</last_update_submitted>
  <last_update_submitted_qc>March 24, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2008</last_update_posted>
  <responsible_party>
    <name_title>khrouf naima</name_title>
    <organization>Hopital La Rabta</organization>
  </responsible_party>
  <keyword>patent</keyword>
  <keyword>ductus</keyword>
  <keyword>arteriosus</keyword>
  <keyword>ibuprofen</keyword>
  <keyword>premature</keyword>
  <keyword>infant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Birth Weight</mesh_term>
    <mesh_term>Ductus Arteriosus, Patent</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

